J. Paul Burnett - Concepedia

Concepedia

Author

J. Paul Burnett

Eli Lilly (United States)

Also Known As

J P Burnett, J PAUL BURNETT, J. Burnett, J. P. Burnett, J. PAUL BURNETT, J. Paul Burnett, J.P BURNETT, J.P Burnett, J.P. Burnett, J.Paul Burnett

39

Publications

1.9K

Citations

22

H-Index

70

Concepts

All Affiliations

Eli Lilly (United States)Eli Lilly (United Kingdom)

JP

About

J. Paul Burnett is an author at Eli Lilly (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.3K
2	Natural Sciences	7	7	579
3	Social Sciences	4	4	232
4	Engineering	2	2	333
5	Health Sciences	1	1	34

J. Paul Burnett

×

27

Publications

1.9K

Citations

22

H-Index

	Year	Citations
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors Anne Kingston, Paul L. Ornstein, Rebecca A. Wright, Neuropharmacology Functional SelectivityMedicineDrug DiscoveryMechanism Of ActionReceptor (Biochemistry)	1998	364
Cytoplasmic Inclusion Bodies in <i>Escherichia coli</i> Producing Biosynthetic Human Insulin Proteins Daniel C. Williams, Richard M. Van Frank, William L. Muth, Science EngineeringProtein AssemblyMolecular BiologyEscherichia ColiInsulin Signaling	1982	312
LY354740 is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate Receptors Darryle D. Schoepp, Bryan G. Johnson, Rebecca A. Wright, Neuropharmacology Functional SelectivityMedicineNeurotransmitterNeuropharmacologyNeuroscience	1997	225
The Novel Metabotropic Glutamate Receptor Agonist 2 R ,4 R -APDC Potentiates Stimulation of Phosphoinositide Hydrolysis in the Rat Hippocampus by 3,5-dihydroxyphenylglycine: Evidence for a Synergistic Interaction Between Group 1 and Group 2 Receptors Darryle D. Schoepp, Craig R. Salhoff, Rebecca A. Wright, Neuropharmacology Rat HippocampusPhosphoinositide HydrolysisGroup 2NeurophysiologyMedicine	1996	105
Pharmacological analysis of 4-carboxyphenylglycine derivatives: Comparison of effects on mGluR1α and mGluR5a subtypes Ann E. Kingston, J. Paul Burnett, Nancy G. Mayne, Neuropharmacology Molecular PharmacologyPharmacological StudyBiochemistryMedicine4-Carboxyphenylglycine Derivatives	1995	89
Binding of ethidium bromide to double-stranded ribonucleic acid Richard J. Douthart, J. Paul Burnett, F. W. Beasley, Biochemistry Nucleic Acid ChemistryBioorganic ChemistryBiochemistryNatural SciencesBiomolecular Analysis	1973	75
Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate Darryle D. Schoepp, Bryan G. Johnson, Craig R. Salhoff, Neuropharmacology Rat HippocampusSelective InhibitionMolecular PhysiologyNeurophysiologyMedicine	1995	74
Cloning and expression of a human metabotropic glutamate receptor 1 alpha: enhanced coupling on co-transfection with a glutamate transporter. Manisha Desai, J. Paul Burnett, Nancy G. Mayne, Molecular Pharmacology	1995	72
(2<i>S</i>,4<i>S</i>)-2-Amino-4-(4,4-diphenylbut-1-yl)- pentane-1,5-dioic Acid: A Potent and Selective Antagonist for Metabotropic Glutamate Receptors Negatively Linked to Adenylate Cyclase Camille G. Wermuth, André Mann, Angèle Schoenfelder, Journal of Medicinal Chemistry Metabotropic Glutamate ReceptorsSynaptic TransmissionAltmetric Attention ScorePeptide SciencePharmacotherapy	1996	58
Base Composition and Hybridization Studies of the Three Double-Stranded RNA Segments of Bacteriophage φ6 James L. Van Etten, Anne K. Vidaver, R. K. Koski, Journal of Virology Bacteriophage φ6Base CompositionNatural SciencesRna Structure PredictionBacteriophage	1974	45

Page 1